Show simple item record

dc.contributor.authorLetrado, Patricia; email: patricia.letrado@ikanbiotech.com
dc.contributor.authorMole, Holly; email: holly.mole@manchester.ac.uk
dc.contributor.authorMontoya, María; email: mmontoya68@gmail.com
dc.contributor.authorPalacios, Irene; email: irene.palacios@cnic.es
dc.contributor.authorBarriuso, Jorge; orcid: 0000-0002-5641-9105; email: jorge.barriuso@manchester.ac.uk
dc.contributor.authorHurlstone, Adam; orcid: 0000-0001-5260-9457; email: adam.hurlstone@manchester.ac.uk
dc.contributor.authorDíez-Martínez, Roberto; email: roberto.diez@ikanbiotech.com
dc.contributor.authorOyarzabal, Julen; email: julenoyarzabal@external.unav.es
dc.date.accessioned2021-07-24T23:26:05Z
dc.date.available2021-07-24T23:26:05Z
dc.date.issued2021-07-23
dc.identifierhttps://chesterrep.openrepository.com/bitstream/handle/10034/625372/cancers-13-03705.pdf?sequence=2
dc.identifierhttps://chesterrep.openrepository.com/bitstream/handle/10034/625372/additional-files.zip?sequence=3
dc.identifierhttps://chesterrep.openrepository.com/bitstream/handle/10034/625372/cancers-13-03705.xml?sequence=4
dc.identifier.citationCancers, volume 13, issue 15, page e3705
dc.identifier.urihttp://hdl.handle.net/10034/625372
dc.descriptionFrom MDPI via Jisc Publications Router
dc.descriptionHistory: accepted 2021-07-19, pub-electronic 2021-07-23
dc.descriptionPublication status: Published
dc.descriptionFunder: Gobierno de Navarra; Grant(s): 0011-1408-2016-000004, 0011-1365-2020-000292
dc.description.abstractZebrafish embryo tumor transplant models are widely utilized in cancer research. Compared with traditional murine models, the small size and transparency of zebrafish embryos combined with large clutch sizes that increase statistical power and cheap husbandry make them a cost-effective and versatile tool for in vivo drug discovery. However, the lack of a comprehensive analysis of key factors impacting the successful use of these models impedes the establishment of basic guidelines for systematic screening campaigns. Thus, we explored the following crucial factors: (i) user-independent inclusion criteria, focusing on sample homogeneity; (ii) metric definition for data analysis; (iii) tumor engraftment criteria; (iv) image analysis versus quantification of human cancer cells using qPCR (RNA and gDNA); (v) tumor implantation sites; (vi) compound distribution (intratumoral administration versus alternative inoculation sites); and (vii) efficacy (intratumoral microinjection versus compound solution in media). Based on these analyses and corresponding assessments, we propose the first roadmap for systematic drug discovery screening in zebrafish xenograft cancer models using a melanoma cell line as a case study. This study aims to help the wider cancer research community to consider the adoption of this versatile model for cancer drug screening projects.
dc.languageen
dc.publisherMDPI
dc.rightsLicence for this article: https://creativecommons.org/licenses/by/4.0/
dc.sourceeissn: 2072-6694
dc.subjectzebrafish
dc.subjectroadmap
dc.subjectdrug discovery
dc.subjectscreening
dc.subjectxenograft
dc.subjectcancer
dc.titleSystematic Roadmap for Cancer Drug Screening Using Zebrafish Embryo Xenograft Cancer Models: Melanoma Cell Line as a Case Study
dc.typearticle
dc.date.updated2021-07-24T23:26:05Z
dc.date.accepted2021-07-19


Files in this item

Thumbnail
Name:
cancers-13-03705.pdf
Size:
4.244Mb
Format:
PDF
Thumbnail
Name:
additional-files.zip
Size:
4.743Mb
Format:
Unknown
Thumbnail
Name:
cancers-13-03705.xml
Size:
10.04Kb
Format:
XML

This item appears in the following Collection(s)

Show simple item record